Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00454805
Status:
COMPLETED
Last Update Posted:
2016-08-03
First Post:
2007-03-29
Brief Title:
AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
None
Primary Completion Date:
2008-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-29
First Submit QC Date:
March 30 2007
Study First Post Date:
2007-04-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-11-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2011-04-06
Disp First Submit QC Date:
April 6 2011
Disp First Post Date:
2011-04-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-07-06
Last Update Post Date:
2016-08-03
Last Update Post Date Type:
ESTIMATED